The disruption of calcineurin signaling facilitates the degradation of TTP, which results in an enhanced pro-inflammatory cytokine/chemokine production, increased skin inflammation and keratinocyte tumorigenesis. This evidence concerns the gene ZFP36 and dermatitis.